# Pandion Therapeutics Inc. (PAND) Source: https://www.quantisnow.com/company/PAND Generated: 2026-11-07T02:00:58.158Z - Ticker: PAND - Exchange: NASDAQ - Sector: n/a - Industry: n/a - IPO year: 2020 ## Latest PAND news and filings - 2021-05-17 20:35 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Pandion Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-pandion-therapeutics-inc-amendment-751918) - 2021-04-12 10:54 UTC [SEC Form 15-12B] [SEC Form 15-12B filed by Pandion Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-15-12b-filed-by-pandion-therapeutics-inc-606406) - 2021-04-08 21:24 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Pandion Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-pandion-therapeutics-inc-amendment-602191) - 2021-04-06 04:15 UTC [SEC Form EFFECT filed by Pandion Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-pandion-therapeutics-inc-588890) - 2021-04-06 04:15 UTC [SEC Form EFFECT filed by Pandion Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-pandion-therapeutics-inc-588881) - 2021-04-02 13:54 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Pandion Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-pandion-therapeutics-inc-amendment-581067) - 2021-04-01 23:59 UTC [SEC Form 4] [SEC Form 4: L. Joanne Viney decreased direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-l-joanne-viney-decreased-direct-ownership-by-580092) - 2021-04-01 23:58 UTC [SEC Form 4] [SEC Form 4: Vikas Goyal decreased direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-vikas-goyal-decreased-direct-ownership-by-100-580091) - 2021-04-01 23:57 UTC [SEC Form 4] [SEC Form 4: L Alan Crane decreased direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-l-alan-crane-decreased-direct-ownership-by-580086) - 2021-04-01 23:55 UTC [SEC Form 4] [SEC Form 4: D. Edward Freedman decreased direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-d-edward-freedman-decreased-direct-ownership-by-580083) - 2021-04-01 23:53 UTC [SEC Form 4] [SEC Form 4 filed by Gregg Beloff](https://www.quantisnow.com/insight/sec-form-4-filed-by-gregg-beloff-580076) - 2021-04-01 23:50 UTC [SEC Form 4] [SEC Form 4: Rahul Kakkar decreased direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-rahul-kakkar-decreased-direct-ownership-by-100-580064) - 2021-04-01 23:49 UTC [SEC Form 4] [SEC Form 4 filed by Christopher Fuglesang](https://www.quantisnow.com/insight/sec-form-4-filed-by-christopher-fuglesang-580063) - 2021-04-01 23:49 UTC [SEC Form 4] [SEC Form 4: J. Daniel Becker decreased direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-j-daniel-becker-decreased-direct-ownership-by-580060) - 2021-04-01 23:46 UTC [SEC Form 4] [SEC Form 4: John Sundy decreased direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-john-sundy-decreased-direct-ownership-by-100-580055) - 2021-04-01 23:46 UTC [SEC Form 4] [SEC Form 4: Nancy Stagliano decreased direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-nancy-stagliano-decreased-direct-ownership-by-100-580052) - 2021-04-01 23:45 UTC [SEC Form 4] [SEC Form 4 filed by Katina Dorton](https://www.quantisnow.com/insight/sec-form-4-filed-by-katina-dorton-580047) - 2021-04-01 23:45 UTC [SEC Form 4] [SEC Form 4: Donald Frail decreased direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-donald-frail-decreased-direct-ownership-by-100-580045) - 2021-04-01 23:43 UTC [SEC Form 4] [SEC Form 4 filed by Jill Carroll](https://www.quantisnow.com/insight/sec-form-4-filed-by-jill-carroll-580038) - 2021-04-01 23:38 UTC [SEC Form 4] [SEC Form 4 filed by Rizzuto Carlo](https://www.quantisnow.com/insight/sec-form-4-filed-by-rizzuto-carlo-580025) - 2021-04-01 23:37 UTC [SEC Form 4] [SEC Form 4: D Eric Larson decreased direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-d-eric-larson-decreased-direct-ownership-by-580022) - 2021-04-01 12:49 UTC [SEC Form S-8 POS filed by Pandion Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-pandion-therapeutics-inc-576360) - 2021-04-01 12:48 UTC [SEC Form S-8 POS filed by Pandion Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-pandion-therapeutics-inc-576357) - 2021-04-01 12:47 UTC [SEC Form POS AM filed by Pandion Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-pandion-therapeutics-inc-576352) - 2021-04-01 12:46 UTC [SEC Form POS AM filed by Pandion Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-pandion-therapeutics-inc-576347) - 2021-04-01 12:45 UTC [SEC Form 8-K] [Pandion Therapeutics Inc. filed SEC Form 8-K: Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change Of Fiscal Year, Financial Statements And Exhibits](https://www.quantisnow.com/insight/pandion-therapeutics-inc-filed-sec-form-8-k-completion-of-acquisition-576327) - 2021-04-01 12:43 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Pandion Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-pandion-therapeutics-inc-576317) - 2021-04-01 12:37 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Pandion Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-pandion-therapeutics-inc-576270) - 2021-04-01 12:30 UTC [Mergers & Acquisitions] [Merck Completes Acquisition of Pandion Therapeutics](https://www.quantisnow.com/insight/merck-completes-acquisition-of-pandion-therapeutics-576201) - 2021-04-01 12:25 UTC [SEC Form 25-NSE filed by Pandion Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-pandion-therapeutics-inc-576122) - 2021-03-31 20:01 UTC [SEC Form 10-K] [SEC Form 10-K/A filed by Pandion Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-ka-filed-by-pandion-therapeutics-inc-573029) - 2021-03-22 20:31 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Pandion Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-pandion-therapeutics-inc-536771) - 2021-03-22 20:21 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Pandion Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-pandion-therapeutics-inc-536667) - 2021-03-12 22:04 UTC [SEC Form S-8 filed](https://www.quantisnow.com/insight/sec-form-s-8-filed-507444) - 2021-03-12 21:40 UTC [SEC Form 10-K filed](https://www.quantisnow.com/insight/sec-form-10-k-filed-507255) - 2021-03-04 22:15 UTC [SEC Form SC 14D9 filed](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-475334) - 2021-03-04 21:48 UTC [SEC Schedule 13D] [SEC Form SC 13D filed](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-475031) - 2021-03-04 21:34 UTC [SEC Form SC TO-T filed](https://www.quantisnow.com/insight/sec-form-sc-to-t-filed-474889) - 2021-03-04 13:24 UTC [Analyst Coverage Resumed] [SVB Leerink resumed coverage on Pandion Therapeutics with a new price target](https://www.quantisnow.com/insight/svb-leerink-resumed-coverage-on-pandion-therapeutics-with-a-new-471959) - 2021-03-04 13:24 UTC [Analyst Coverage Resumed] [Morgan Stanley resumed coverage on Pandion Therapeutics with a new price target](https://www.quantisnow.com/insight/morgan-stanley-resumed-coverage-on-pandion-therapeutics-with-a-new-471855) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/PAND - Earnings history: https://www.quantisnow.com/earnings/PAND - Dividend history: https://www.quantisnow.com/dividends/PAND - Insider transactions: https://www.quantisnow.com/insiders/PAND - Options chain: https://www.quantisnow.com/options/PAND - SEC 8-K filings only: https://www.quantisnow.com/company/PAND/8-k - RSS and alerts for PAND: https://www.quantisnow.com/docs/rss-feeds.md